Purna Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Purna Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2008-09-02 Kolkata, West Bengal Dissolved (Liquidated) Unlisted Active Non-Compliant
Share
PP Purna Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Purna Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
56/100
Trust Score
Moderate

Purna Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 56/100. Purna Pharmaceuticals Private Limited is a private limited indian non-government company incorporated in 2008, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Purna Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (D).

Charges position: 2 open (18.00 cr) · 2 satisfied (16.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others2 48.0 cr
State Bank Of India2 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is "Dissolved (Liquidated)" - not Active.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2016 - filings overdue.
  • Flagged by authority: NCLT.
  • Litigation present in 2 court forum(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAMDEO RAM 01234567 Director 01/04/2018 6 yrs Approved
PHOOL CHANDRA YADAV 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 10 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 45
Growth signals & trust indicators
Revenue acceleration: +2.1x over 2 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 17+ years.
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
Adverse company status: Dissolved (Liquidated).
Compliance score is weak (5/100).
2 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence32/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 18.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
16 Dec 2019
Director appointed
RAMDEO RAM (Director)
Director appointed
PHOOL CHANDRA YADAV (Director)
Director ceased
ADITYA BALASARIA
29 Sep 2017
Director ceased
MADHUSUDAN BALASARIA
21 Jun 2017
Director ceased
NATASHA BALASARIA
10 Nov 2016
Charge created
Others - 3.00 cr
26 Sep 2016
Last AGM held
Annual general meeting
31 Mar 2016
Share transfer (FY 2016)
10000 shares to VERIZON LABS PRIVATE LIMITED
Share transfer (FY 2016)
14000 shares to ADITYA BALASARIA HUF
Share transfer (FY 2016)
10000 shares to VDK REALITY PRIVATE LIMITED
Share transfer (FY 2016)
60000 shares to ADITYA
Share transfer (FY 2016)
10000 shares to CONCEPTUAL BIOSCIENCES PRIVATE LIMIT
Share transfer (FY 2016)
10000 shares to STREBUF PHARMA PRIVATE LIMITED
Share transfer (FY 2016)
30000 shares to NATASHA
Share transfer (FY 2016)
10000 shares to WELLWORTH PHARMACEUTICALS PVT. LTD.
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
Carries an external credit rating of D from Care.
Promoters hold a majority stake as per the FY 2016 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Hi-Tech Air Power Private Limited U29120KA2000PTC028063 Bangalore., Karnataka, India
Nilabh Trading Private Limited U51101GJ2013PTC077931 Surat, Gujarat, India
V. R. N. Enterprises Private Limited U17111KA2004PTC033705 Bangalore, Karnataka, India
Sardar Associates Private Limited U27105PB1982PTC005088 Punjab, Punjab, India
Akku Marketing Private Limited U51109WB2008PTC124064 Kolkata, West Bengal, India
Yatinraj Trading Private Limited U51909GJ2013PTC077176 Surat, Gujarat, India
Vision Millennium Exports Private Limited U51900MH1998PTC117622 Navi Mumbai, Maharashtra, India
Shaurya Sales Agencies Private Limited U51101HR2014PTC053803 Faridabad, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Purna Pharmaceuticals Private Limited before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Purna Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Purna Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Purna Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Purna Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Purna Pharmaceuticals Private Limited an active company?

Purna Pharmaceuticals Private Limited has MCA status “Dissolved (Liquidated)” with a compliance score of 5/100 (Caution Indicated).

Is Purna Pharmaceuticals Private Limited financially healthy?

Purna Pharmaceuticals Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Purna Pharmaceuticals Private Limited?

Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Purna Pharmaceuticals Private Limited?

Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Purna Pharmaceuticals Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Purna Pharmaceuticals Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Purna Pharmaceuticals Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.